Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients-Reference-Cited by-同舟云学术

Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients

Published:2011-05 Issue:21 Volume:29 Page:3738-3741
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lin Shih-Yi,Liu Jiung-Hsiun,Lin Chung-Chih,Wang Su-Ming,Tsai Chen-An,Chou Che-Yi,Kuo Huey-Liang,Wang I.-Kuan,Liu Yao-Lung,Lin Hsin-Hung,Huang Chiu-Ching

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Hepatitis B virus infection;Dienstag;N Engl J Med,2008

2. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: Immunization of adults. Appendix B;CDC;MMWR,2005

3. Antibody levels and protection after Hepatitis B vaccination: results of a 15-year follow-up;McMahon;Ann Intern Med,2005

4. Hepatitis B vaccine in patients receiving hemodialysis;Stevens;N Engl J Med,1984

5. Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients;Pasko;Am J Kidney Dis,1988

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China;Expert Review of Vaccines;2022-08-18

2. Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study;The Lancet Regional Health - Europe;2022-06

3. Immunogenicity and tolerability of COVID‐19 vaccination in peritoneal dialysis patients—A prospective observational cohort study;Seminars in Dialysis;2021-12

4. Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines;Nephrology Dialysis Transplantation;2021-11-15

5. Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China;Vaccine;2021-04